Detalles de la búsqueda
1.
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.
Acta Derm Venereol
; 102: adv00698, 2022 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35146532
2.
Secukinumab Self-Administration by Prefilled Syringe Maintains Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE Trial.
J Drugs Dermatol
; 15(10): 1226-1234, 2016 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27741340
3.
Fracture risk and zoledronic acid therapy in men with osteoporosis.
N Engl J Med
; 367(18): 1714-23, 2012 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23113482
4.
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
Rheumatology (Oxford)
; 52(6): 1058-69, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23365149
5.
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
Am J Clin Dermatol
; 24(5): 821-835, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341961
6.
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study.
Paediatr Drugs
; 24(4): 377-387, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35698000
7.
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet
; 373(9671): 1253-63, 2009 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-19362675
8.
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
J Bone Miner Res
; 26(3): 503-11, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20814967
9.
Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.
Arthritis Rheum
; 54(5): 1410-4, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16645968
Resultados
1 -
9
de 9
1
Próxima >
>>